Latest Corporate News


Montreal, July 16, 2019 — On July 6 and 7, the Pharmascience Team cycled more than 200 kilometres for the Enbridge® Ride to Conquer Cancer benefiting the Segal Cancer Centre at the Jewish General Hospital.  

The Ride to Conquer Cancer is a fundraising event during which participants bike from Montreal to Quebec City over the span of two days, for a total 230 kilometres. The event has garnered a spirited success for many years and rallies an entire community in support of one single cause: to raise funds to advance cancer research. This year thousands of participants and their peers collectively raised $4.2 million for the Segal Cancer Centre at the Jewish General Hospital.

For many years now, Pharmascience has been a proud sponsor of the Ride to Conquer Cancer. Given Pharmascience’s continued dedication to helping advance cancer research, we are pleased to announce our intention to renew its commitment in 2020 at the 12th edition of the Enbridge® Ride to Conquer Cancer. This year, Pharmascience was ranked 10th in its category for its fundraising efforts. The team raised a total of $75,894.87. Since Pharmascience first participated in the race in 2011, the team has raised more than half a million dollars!

Pharmascience demonstrates its unwavering commitment to cancer research through the Goodman Cancer Research Center, a recognized world-class research center that contributes to innovative developments in the treatment and, ultimately, the cure for cancer.

Special thanks to all our cyclists and donors for this 11th edition of the Enbridge® Ride to Conquer Cancer:

Valérie Pilon (captain), Stephane Charland (captain), Lori Anders, Diana Barrero, Alphee Beauchamp, Dominique Bray, Francois Bujold, Carlo De Luca, Martin Drolet, Richard Garon, Jad Isber, Kurt Koscher, Genevieve Larouche, Jean Francois Lemieux, Karim Mtalsi, Francoise Munger, Marc Nadeau, Elisabeth Nguyen, Steven Nguyen, Audrée Perreault, Deanna Rabinovitz, Annick Stolk et Cristina Tita.

About Pharmascience Inc. 

Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Québec with over 1,500 employees proudly headquartered in Montréal. Pharmascience Inc. is a full-service, privately owned pharmaceutical company that has strong roots in Canada and a growing global reach, with product distribution in over 60 countries. Ranked 56th among Canada's top 100 Research & Development (R&D) investors with over $43 million invested in 2017, Pharmascience Inc. is the third-largest manufacturer of over-the-counter generic drugs in the country.

Pharmascience Inc. is a leading manufacturer and marketer of prescription generic, over-the-counter, and behind-the-counter products as well as FDA-approved Canadian-made injectables. The company commercializes nearly 300 product families in 20 different dosage forms for over 2,000 products. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products.

In 2018, Forbes magazine ranked Pharmascience Inc. among its list of top 300 employers. Pharmascience Inc. has strong long-standing philanthropic ties with its communities, both locally and internationally. For more than 20 years, Pharmascience has been working through Health Partners International of Canada (HPIC) as a partner of choice to increase access to medicine. Pharmascience's donations of essential medicine total close to $70 million.


Back to News